Read next
Health
GLP-1 Supply Disruption Analysis Points to Active Ingredient Bottlenecks
Pharmaceutical manufacturers struggle to expand output of peptide active ingredients, threatening global distribution schedules for weight-management therapeutics.
Health
Synthetic Biology Accelerates Targeted Protein Degradation Therapies
Clinical trial pipelines show a sharp increase in PROTAC candidates aimed at previously undruggable disease targets.
Health
RNA-Based Therapeutics Expand Target Applications Beyond Oncology
Clinical trials yield positive data for targeted messenger RNA therapies in cardiovascular and metabolic disorders.
Health
Targeted Peptide Therapeutics Accelerate Phase III Clinical Milestones
Biopharmaceutical firms are leveraging automated synthesis platforms to target previously undruggable intracellular pathway proteins.
Health
GLP-1 Supply Chain Disruption Forces Clinical Prioritization
Pharmaceutical manufacturers struggle to balance global demand for metabolic treatments with critical diabetes care requirements.
Health
GLP-1 Drug Adoption Reshapes Consumer Goods and Grocery Retail Volumes
Widespread utilization of anti-obesity medications is correlating with measurable drops in caloric product sales across North American grocery…